The Central Okanagan in January had the lowest unemployment rate in Canada.
The region’s jobless late remained steady in January at 4.6%, which is the lowest mark among Canada’s 37 major metropolitan areas, according to Statistics Canada.
The Kelowna metropolitan area, which includes West Kelowna, experienced a decrease of approximately 1,500 workers from December to January, but the unemployment rate did not change.
The 4.6% mark is only two-tenths of a percentage higher than the region’s unemployment rate in January 2020—two months prior to COVID-19 shutdowns.
Quebec City had the nation’s second lowest January unemployment rate at 4.7%.
The unemployment rate in B.C. last month was eight per cent, up from 7.2 per cent in December. The national jobless rate was 9.4 per cent in January, up from 8.8 per cent in December, and economists say that’s mainly due to the loss of hundreds of thousands of service sector jobs, most in Ontario and Quebec.
The vaccine experts say extending the dose interval to four months can protect the entire adult population within a short time despite limited supply.
Author of the article:
The Canadian Press
Publishing date:
Mar 03, 2021 • 11 hours ago • 2 minute read • 14 Comments
Dr. Bonnie Henry says more than 6,000 people have died from overdoses over the past five years.Photo by DON CRAIG/GOVERNMENT OF B.C. /PNG
Article content
Taking a cue from B.C.’s top doctor, a national panel of vaccine experts recommended that provinces extend the interval between the two doses of a COVID-19 shot to up to four months when faced with a limited supply, in order to quickly immunize as many people as possible.
The National Advisory Committee on Immunization issued updated guidance Wednesday for the administration of all COVID-19 vaccines currently approved for use in Canada.
Extending the dose interval to four months will create opportunities to protect the entire adult population against the virus within a short time frame, the panel said in releasing the recommendation.
As many as 80 per cent of Canadians over 16 could receive a single dose by the end of June simply with the expected supply of Pfizer-BioNTech and Moderna vaccines, the panel said.
The addition of the newly approved Oxford-AstraZeneca vaccine to the country’s supply could mean almost all Canadians would get their first shot in that time frame, but the federal government has not yet said how many doses of that vaccine will be delivered in the spring and how many in the summer.
Article content
“The vaccine effectiveness of the first dose will be monitored closely and the decision to delay the second dose will be continuously assessed based on surveillance and effectiveness data and post-implementation study designs,” the panel wrote.
“Effectiveness against variants of concern will also be monitored closely, and recommendations may need to be revised,” it said, adding there is currently no evidence that a longer interval will affect the emergence of the variants.
The committee’s recommendation came hours after Newfoundland and Labrador said it will extend the interval between the first and second doses to four months, and days after B.C. health officer Dr. Bonnie Henry announced the province was doing so.
Manitoba also said Wednesday it will delay second doses in order to focus on giving the first shot to more people more quickly.
Ontario previously said it was weighing a similar move but would seek advice from the federal government.
Get the latest COVID-19 news delivered to your inbox weeknights at 7 p.m. by subscribing to our newsletter here.
Trudeau held to his September target, but said with vaccine deliveries being moved up and new candidates being approved, the timeline could be moved up
Author of the article:
Ryan Tumilty
Publishing date:
Mar 04, 2021 • 8 hours ago • 4 minute read • 41 Comments
“We’re very optimistic that we’re going to be able to accelerate some of these timelines,” Trudeau said.Photo by Gary Clement/National Post
Article content
OTTAWA – Prime Minister Justin Trudeau said Wednesday morning he was hopeful Canada’s vaccine timelines could be moved up, but offered no assurance the vaccine rollout here won’t be completed months after the United States.
But late on Wednesday afternoon, a national panel of vaccine experts recommended extending the interval between the two doses of a COVID-19 shot when faced with a limited supply.
Canada’s National Advisory Committee on Immunization’s updated guidance is for the administration of all COVID-19 vaccines currently approved for use in Canada. It says extending the dose interval to four months will create opportunities to protect the entire adult population against the virus within a shorter timeframe.
U.S. President Joe Biden said Tuesday evening America would have enough vaccines delivered to cover the entire population by late May. The rollout of those vaccines into arms will follow, but America is still likely to be able to vaccinate its entire population months ahead of Canada.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Trudeau’s long-held timeline is to have all Canadians vaccinated by the end of September. He held to that target at his Wednesday morning press conference, but said with vaccine deliveries being moved up and new candidates being approved, it is possible the timeline could be moved up.
“We’re very optimistic that we’re going to be able to accelerate some of these timelines,” he said. “We’re going to continue to do everything we can to allow our population to get through this challenge as quickly as possible,” he said.
Trudeau said COVID has had a much more devastating impact on the U.S. and that will have a significant impact on the recovery.
“Obviously, the pandemic has had a very different course in the United States with far greater death tolls and case counts and that has had its own impact on the American economy,” he said.
Conservative MP Michelle Rempel Garner, the party’s health critic, said the government should be providing a clearer, more detailed explanation of its vaccine plan, to help businesses have confidence about what comes next.
“We don’t have any of that data. We don’t actually know what the realistic time horizon is for delivery of vaccines,” she said.
With Canada set to be months behind the U.S., United Kingdom and potentially other countries in the rollout, Rempel Garner said the government should be offering information about what else it will do to ease the pandemic in the meantime.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
“I think we’ll have a problem on compliance and certainty for business reopening, so this is why we’re saying look, be honest with Canadians, and then let’s work together to come up with a plan B,” she said. “COVID fatigue is a real thing. There’s a lot of frustration.”
Trudeau announced that both the government’s rent subsidy for small business and the wage subsidy will be extended into June as the pandemic continues. The extension of the rent subsidy is forecasted to cost an additional $2.1 billion and the wage subsidy will cost the government an additional $13.9 billion.
Finance Minister Chyrstia Freeland said the government would continue to support businesses with the goal of keeping the economy moving so it can resurge quickly when restrictions are lifted.
“Our government will continue to do whatever it takes for as long as it takes to help Canadians through this bleak time, to prevent economic scarring and invest in a way that allows us all to come roaring back,” she said.
Biden moved up his timeline to May, from what had been the end of July, after announcing the U.S. government had approved a third vaccine candidate from Johnson and Johnson. Canada is expected to approve that vaccine soon.
Canada received 500,000 doses of the AstraZeneca vaccine, the first shipment in a total of two million doses expected before mid-May, on top of a further 20 million doses expected between April and September.
Despite all the recent vaccine announcements, Trudeau said it was too early to formally move up the deadline, because there could still be issues with manufacturing or deliveries.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
“These are new processes for new vaccines that are being manufactured in the millions and even billions in order to cover everyone on Earth,” he said. “We’ll be facing continued challenges, which is one of the reasons why we made such a deliberate effort to sign more deals with more different companies than many of our fellow countries.”
While the Biden administration has said it won’t ship vaccines from the U.S. to other countries until all Americans are vaccinated, Trudeau said Biden knows the challenge is global.
“It was very clear that they understand, like us, we know that you don’t get through this pandemic, anywhere, not fully, until you get through it everywhere.”
Sign up to receive the daily top stories from the National Post, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300
Thanks for signing up!
A welcome email is on its way. If you don’t see it please check your junk folder.
The next issue of Posted Newsletter will soon be in your inbox.
We encountered an issue signing you up. Please try again
Nova Scotia has decided to receive its first shipment of the Oxford-AstraZeneca vaccine.
Next week, the province will get 13,000 doses of the third COVID-19 vaccine approved for use by Health Canada.
They don’t have a long shelf life and must be used by April 2.
Because of that, even though it is a two dose vaccine, the province announced today it plans to administer all of the supply as first doses. They will be going into the arms of Nova Scotians between the ages of 50 and 64 at 26 locations throughout the province on a first-come, first-served basis.
Earlier this week, the National Advisory Committee on Immunization recommended the Oxford-AstraZeneca only be used for people between the ages of 18 and 64.
“AstraZeneca is different than the two vaccines we’re using now,” explained the province’s chief medical officer of health at Tuesday’s briefing. “The Pfizer-BioNtech and the Moderna are mRNA vaccines, which have been shown to be 94 to 95 per cent effective in preventing symptomatic COVID-19 illness.”
“The AstraZeneca is slightly different. It’s called a viral-vector vaccine and it’s been shown to be about 62 per cent effective against preventing symptomatic illness.”
Because of that, Dr. Robert Strang said it won’t be used for any group considered to be a high risk for severe disease and/or exposure.
Unlike the mRNA vaccines, the Oxford-AstraZeneca vaccine does contain a virus, however the province says it isn’t the one that causes COVID-19. It’s a “different, harmless virus that triggers an immune response.”
The vaccine also doesn’t need the cold or ultra-low cold storage that the other two require. It can be stored between 2 and 8 degrees Celsius, which is similar to the standard flu vaccine.
Doctors Nova Scotia and the Pharmacy Association of Nova Scotia will be handling the launch.
“This vaccine provides another tool in our fight against COVID-19 and builds on the roll-out that is already underway in our province as we work to vaccinate all Nova Scotians,” said Premier Iain Rankin in a news release. “We have to move fast as we are mindful of the fact that we have a short window to use it given that they will expire in a month.”
Canadanewsmedia uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.